Yhdysvallat - englanti - NLM (National Library of Medicine)

rite aid - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride 0.05 kg in 100 l - aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

western family foods, inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride .05 kg in 100 l - aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

mckesson - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride 0.05 kg in 100 l - anticavity rinse aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

kirkman group, inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.55 mg in 0.6 ml - for once daily, self-administered, systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f) during the period of tooth development results in a significant decrease in the incidence of dental caries. perry fluorabon drops (0.25 mg fluoride ion per 0.6 ml) were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 16 years of age living in areas where the drinking water fluoride content does not exceed 0.6 ppm (f). perry fluorabon drops (0.25 mg fluoride ion per .6 ml), are contraindicated when the fluoride content of drinking water is 0.6 ppm (f) or more and should not be administered to pediatric patients under the age of 6 months. do not administer fluoride (any strength) to pediatric patients under age 6 months.

Yhdysvallat - englanti - NLM (National Library of Medicine)

chattem, inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.2 mg in 1 ml - anticavity - aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

chattem, inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.2 mg in 1 ml - anticavity - aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

topco associates, llc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.2 mg in 1 ml - anticavity rinse aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

meijer distribution, inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.2 mg in 1 ml - anticavity rinse aids in the prevention of dental cavities

Yhdysvallat - englanti - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.5 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 6 years of age when the fluoride content of drinking water is 0.3 ppm f* or to pediatric patients under age 3 years. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.

Yhdysvallat - englanti - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 0.25 mg are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f* and should not be administered to pediatric patients under 3 years of age when the fluoride content of drinking water is 0.3 ppm f* or more. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.